These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26320630)

  • 1. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
    Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
    Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
    Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
    Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2: Role of Val135 in Transfer of Lipopolysaccharide from CD14 to MD-2.
    Vašl J; Oblak A; Peternelj TT; Klett J; Martín-Santamaría S; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2016 Mar; 196(5):2309-18. PubMed ID: 26826249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
    Ohto U; Fukase K; Miyake K; Shimizu T
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of membrane and soluble forms of human MD-2.
    Viriyakosol S; Tobias PS; Kirkland TN
    J Biol Chem; 2006 Apr; 281(17):11955-64. PubMed ID: 16467306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin.
    Resman N; Vasl J; Oblak A; Pristovsek P; Gioannini TL; Weiss JP; Jerala R
    J Biol Chem; 2009 May; 284(22):15052-60. PubMed ID: 19321453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
    Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
    J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.
    Meng J; Lien E; Golenbock DT
    J Biol Chem; 2010 Mar; 285(12):8695-702. PubMed ID: 20018893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain.
    Vasl J; Prohinar P; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2008 May; 180(9):6107-15. PubMed ID: 18424732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
    Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y
    Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural model of MD-2 and functional role of its basic amino acid clusters involved in cellular lipopolysaccharide recognition.
    Gruber A; Mancek M; Wagner H; Kirschning CJ; Jerala R
    J Biol Chem; 2004 Jul; 279(27):28475-82. PubMed ID: 15111623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I.
    Ohto U; Yamakawa N; Akashi-Takamura S; Miyake K; Shimizu T
    J Biol Chem; 2012 Nov; 287(48):40611-7. PubMed ID: 23055527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS/TLR4 complex in silico.
    Mobarak E; Håversen L; Manna M; Rutberg M; Levin M; Perkins R; Rog T; Vattulainen I; Borén J
    Sci Rep; 2018 Sep; 8(1):13600. PubMed ID: 30206272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface.
    Tsukamoto H; Ihara H; Ito R; Ukai I; Suzuki N; Kimoto M; Tomioka Y; Ikeda Y
    Biochem Biophys Res Commun; 2013 Oct; 440(1):31-6. PubMed ID: 24021278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA.
    Meng J; Drolet JR; Monks BG; Golenbock DT
    J Biol Chem; 2010 Sep; 285(36):27935-43. PubMed ID: 20592019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses.
    Barata TS; Teo I; Brocchini S; Zloh M; Shaunak S
    PLoS Comput Biol; 2011 Jun; 7(6):e1002095. PubMed ID: 21738462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.